Liver lesions located adjacent to the middle hepatic vein (MHV) at the hepatocaval confluence are rare. Mini-mesohepatectomy (MMH) allows resection of these lesions with preservation of liver parenchymal volume thus reducing the risk of post-hepatectomy liver failure (PHLF). We evaluated our experience of MMH at our institution and assessed post-operative complications, disease free survival (DFS) and overall survival (OS). All patients undergoing MMH at our institution were included in the study. Intra-operative parameters, histopathological data, DFS and OS were evaluated. 11 patients with colorectal liver metastasis underwent MMH between Jan 2012 and Dec 2020. MMH resulted in R0 resection rate in all patients with no PHLF. There were 1 post-operative bile leaks but no mortality following MMH. Median DFS was 13.5 months with OS being 60 months. MMH offers safe oncological resection of lesions at the MHV at the hepatocaval confluence and should be considered in patients presenting with such lesions.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9284069 | PMC |
| http://dx.doi.org/10.1016/j.ijscr.2022.107363 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Intraoperative HIFU ablation of the liver at the hepatocaval confluence as adjunct to surgery: Preliminary animal experiments.
Ultrasonics
December 2024
LabTAU, INSERM, Centre Leon Berard, Universite Lyon 1, F-69003 LYON, France. Electronic address:
Treating colorectal liver metastases (CLMs) located at the hepatocaval confluence with surgery is challenging due to its complexity and associated high risks of perioperative mortality and morbidity. Moreover, thermal ablation techniques are sensitive to the "heat-sink" effect, which reduces their efficacy when tumors are in contact with major blood vessels. In this study we evaluated the feasibility and safety of an intraoperative high-intensity focused ultrasound (HIFU) device for destroying liver tissue volumes sufficiently large to consider treating CLMs at the hepatocaval confluence.
View Article and Find Full Text PDFCavo-Atrial Inferior Vena Cava (IVC) Restoration With Polytetrafluoroethylene Graft: Overcoming Lethal Injuries.
Cureus
November 2024
Hepato-Pancreato-Biliary Surgery and Liver Transplantation, London Bridge Hospital, London, GBR.
Injuries to the inferior vena cava (IVC) carry high risks and mortality rates. We present a case of suprahepatic IVC injury that was successfully treated with polytetrafluoroethylene (PTFE) graft insertion without cardiopulmonary bypass. A 46-year-old woman was transferred to our trauma centre after a high-speed motor vehicle collision.
View Article and Find Full Text PDFInitial experience of parenchyma-sparing liver resection with systematic selective hepatic vein reconstruction for colorectal metastases.
BMJ Surg Interv Health Technol
December 2024
Bogomolets National Medical University, Kiiv, Ukraine.
Objectives: This study aims to assess the feasibility and short-term and intermediate-term technical success rate of the concept of systematic selective hepatic vein (HV) reconstruction for parenchyma-sparing hepatectomies (PSHs) in patients with colorectal liver metastases (CRLM) in accordance with stage 2a of the IDEAL framework.
Design: The prospective case series of patients deemed eligible and operated on according to the concept.
Setting: All patients were treated by a single surgical team in three hospitals in Ukraine from June 2022 to November 2023.
A retrospective study of irreversible electroporation for tumors adjacent to perihepatic important structure.
Front Oncol
September 2024
Department of Interventional Radiology, Ruijin Hospital Luwan Branch, Shanghai JiaoTong University School of Medicine, Shanghai, China.
Article Synopsis
- * This study analyzed the outcomes of 32 patients with tumors close to these important structures who underwent IRE treatment from 2017 to 2021, using follow-up imaging to track complications and survival rates.
- * Results indicated that IRE was successfully applied to various tumor locations, with a significant portion of lesions located near the porta hepatis and a minority adjacent to the gallbladder, showcasing the potential for expanding IRE's use in challenging clinical settings.
Liver Resection Under Total Hepatic Vascular Exclusion with In Situ Hypothermic Isolated Hepatic Perfusion for Advanced Liver Tumors.
Ann Surg Oncol
September 2024
Department of Surgery, Fukuyama City Hospital, Fukuyama, Japan.
Article Synopsis
- * Case 1 involved a patient with colorectal liver metastasis who underwent surgery but died three months post-operation, with no clear cause of death provided.
- * Case 2 treated hepatocellular carcinoma with extensive tumor involvement, resulting in 8 months of recurrence-free survival and 31 months overall, highlighting THVE with HIHP as a safe approach for liver resections near the hepatocaval confluence.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!